Advancements In AI Technology For Early Sepsis Detection In Hospital-Acquired Infection Control Industry Trends Gaining Momentum in the Global Hospital-Acquired Infection Control Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Hospital-Acquired Infection Control Market Size By 2025?
The size of the market for controlling infections acquired in hospitals has seen a consistent increase over the past years. The market size is set to rise from $34.59 billion in 2024 to $35.86 billion in 2025, a compound annual growth rate (CAGR) of 3.7%. Factors contributing to this growth during the historic period include an increase in antibiotic resistance, heightened awareness, stricter regulations, international spread of infectious diseases, and initiatives directed towards patient safety.

How Big Is the Hospital-Acquired Infection Control Market Size Expected to Grow by 2029?
The market size for hospital-acquired infection control is anticipated to experience robust growth in the approaching years. By 2029, it's projected to expand to a whopping $44.42 billion with a compound annual growth rate (CAGR) of 5.5%. The surge during the forecast period can be linked to the emergence of multidrug-resistant pathogens, readiness for pandemics, heightened surveillance and monitoring, antimicrobial stewardship programs, and international cooperation. The forecast period will also witness major trends such as the utilization of Real-Time Location Systems (RTLS), the integration of Artificial Intelligence (AI) for surveillance, a shift towards single-use and disposable devices, emphasis on staff training and education, and a rise in the use of disinfection technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Which Key Market Drivers Powering Hospital-Acquired Infection Control Market Expansion and Growth?
The spike in cases of COVID-19 is anticipated to bolster the expansion of the hospital-acquired infection control market. COVID-19 is a viral infection caused by the SARS-CoV-2 virus. The pandemic has driven up the demand for hospital-acquired infection control products and services, with a particular focus on personal hygiene and the manufacturing of infection management medical supplies. For example, according to the World Health Organization, a specialized United Nations agency based in Switzerland, the global COVID-19 case count had risen to 581.6 million as of the 8th of August, 2022. Thus, the rising number of COVID-19 instances is fueling the growth of the hospital-acquired infection control market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7694&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Hospital-Acquired Infection Control Market?
Leading corporations in the hospital-acquired infection control sector are dedicating efforts towards designing innovative technological solutions like AI systems to detect early indications of sepsis. The goal is to improve patient results by enabling swift diagnosis and treatment. An AI system for early sepsis identification involves cutting-edge technology that uses artificial intelligence and machine learning for initial sepsis detection in patients. In April 2024, for example, Prenosis Inc., a medical clinic based in the US, secured FDA marketing approval for the Sepsis ImmunoScore. This product, the first of its kind, uses AI to predict sepsis, a detrimental condition which could lead to serious complications. This unique tool improves early detection by analyzing real-time data, empowering healthcare personnel to act faster and more efficiently. AI integration is purposed to aid healthcare workers in decision making, rather than substituting them, consequently enhancing patient outcomes and lowering healthcare expenses.

What Are the Emerging Segments in the Hospital-Acquired Infection Control Market?
The hospital-acquired infection control market covered in this report is segmented -

1) By Product: Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And Surveillance Software, Other Products
2) By Technology: Phenotypic Methods, Genotypic Methods
3) By Diseases: Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection, Other Diseases
4) By Application: Disease Testing, Drug-Resistance Testing
5) By End User: Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Other End Users

Subsegments:
1) By Sterilizers: Steam Sterilizers, Ethylene Oxide Sterilizers, Hydrogen Peroxide Sterilizers
2) By Disinfectors: Washer Disinfectors, Automated Disinfectors
3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors, Automated Endoscope Reprocessors
4) By Microbial Testing Instruments: Culture Systems, Rapid Microbial Testing Systems
5) By Consumables: Sterilization Wraps, Filters, Personal Protective Equipment (PPE)
6) By Disinfectants: Alcohol-based Disinfectants, Chlorine-based Disinfectants, Quaternary Ammonium Compounds
7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions, Data Management Software
8) By Other Products: Cleaning Equipment, Air Purification Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7694&type=smp

Who Are the Global Leaders in the Hospital-Acquired Infection Control Market?
Major companies operating in the hospital-acquired infection control market include Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.

Which are the Top Profitable Regional Markets for the Hospital-Acquired Infection Control Industry?
North America was the largest region in the hospital-acquired infection control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7694

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.